Concepedia

Paulina Pomper

PP

Statistics

Publications

5

Citations

142

H-Index

5

Active since

2020

Affiliations

University of Warsaw(Current)

OncoArendi Therapeutics (Poland)

Medical University of Warsaw

Paulina Pomper is an author at University of Warsaw specializing in pharmacology, molecular pharmacology, and cancer pharmacology.

ORCID

Publications per year

2020–2025

5

Publications

5

Potent but transient immunosuppression of T-cells is a general feature of CD71+ erythroid cells

Tomasz M. Grzywa, Anna Sosnowska, Zuzanna Rydzyńska et al. · Communications Biology · 2021 · 39 citations · Full text

, , +13

OATD-02 Validates the Benefits of Pharmacological Inhibition of Arginase 1 and 2 in Cancer

Marcin Grzybowski, Paulina Seweryna Stańczak, Paulina Pomper et al. · Cancers · 2022 · 37 citations · Full text

, , +11

Arginase 1/2 Inhibitor OATD-02: From Discovery to First-in-man Setup in Cancer Immunotherapy

Bartlomiej Borek, Julita Nowicka, Anna Gzik et al. · Molecular Cancer Therapeutics · 2023 · 32 citations · Full text

, , +12

Metabolomic reprogramming of the tumor microenvironment by dual arginase inhibitor OATD-02 boosts anticancer immunity

Marcin Grzybowski, Yasemin Uçal, Angelika Muchowicz et al. · Scientific Reports · 2025 · 19 citations · Full text

, , +17

Synthesis, evaluation and molecular modelling of piceatannol analogues as arginase inhibitors

Jason Muller, Bruno Cardey, Andy Zedet et al. · RSC Medicinal Chemistry · 2020 · 15 citations · Full text

, , +12

1–5 of 5